Global X Genomics & Biotechnology ETF (GNOM) Holdings
GNOM holdings summary
as of Oct 24, 2026- Holdings
- 50 positions listed
- Top 10 weight
- 54.1% of net assets
- Effective holdings
- 22 equal-weight equivalent
- Largest holding
- MRNA 12.18% Moderna, Inc.
- Annual turnover
- 16.0% of the portfolio traded
All GNOM holdings
| # | Name | ||||||
|---|---|---|---|---|---|---|---|
| 1 | MRNA | Moderna, Inc. | Healthcare | 12.18% | $12.9M | $87.04B | — |
| 2 | TWST | Twist Bioscience Corporation | Healthcare | 6.06% | $6.4M | $8.80B | — |
| 3 | TXG | 10x Genomics, Inc. | Healthcare | 5.99% | $6.3M | $9.10B | — |
| 4 | ILMN | Illumina, Inc. | Healthcare | 5.85% | $6.2M | $39.64B | 49.0 |
| 5 | NTRA | Natera, Inc. | Healthcare | 5.26% | $5.6M | $56.71B | — |
| 6 | GH | Guardant Health, Inc. | Healthcare | 5.01% | $5.3M | $21.28B | — |
| 7 | TECH | Bio-Techne Corporation | Healthcare | 3.45% | $3.6M | $11.38B | 62.6 |
| 8 | 1548 | Genscript Biotech Corp | Healthcare | 3.45% | $3.6M | — | — |
| 9 | QGEN | Qiagen N.V. | Healthcare | 3.41% | $3.6M | $9.53B | 23.4 |
| 10 | VRTX | Vertex Pharmaceuticals Incorporated | Healthcare | 3.41% | $3.6M | $126.66B | 28.9 |
| 11 | BMRN | BioMarin Pharmaceutical Inc. | Healthcare | 2.82% | $3.0M | $10.58B | 147.8 |
| 12 | CAI | Caris Life Sciences, Inc. | Healthcare | 2.67% | $2.8M | $8.64B | 18.1 |
| 13 | CRSP | CRISPR Therapeutics AG | Healthcare | 2.58% | $2.7M | $4.76B | — |
| 14 | VCYT | Veracyte, Inc. | Healthcare | 2.48% | $2.6M | $3.47B | 30.8 |
| 15 | CDNA | CareDx, Inc | Healthcare | 2.35% | $2.5M | $3.31B | 30.8 |
| 16 | BNTX | BioNTech SE | Healthcare | 2.26% | $2.4M | $22.03B | — |
| 17 | ARWR | Arrowhead Pharmaceuticals, Inc. | Healthcare | 2.18% | $2.3M | $7.90B | — |
| 18 | PRAX | Praxis Precision Medicines, Inc. | Healthcare | 2.18% | $2.3M | $6.75B | — |
| 19 | LEGN | Legend Biotech Corporation | Healthcare | 2.02% | $2.1M | $3.59B | — |
| 20 | LLY | Eli Lilly and Company | Healthcare | 2.00% | $2.1M | $1.12T | 42.2 |
| 21 | GILD | Gilead Sciences, Inc. | Healthcare | 1.68% | $1.8M | $193.67B | — |
| 22 | BEAM | Beam Therapeutics Inc. | Healthcare | 1.64% | $1.7M | $2.42B | — |
| 23 | BLLN | BillionToOne, Inc. | Healthcare | 1.56% | $1.7M | $4.63B | 155.7 |
| 24 | SRPT | Sarepta Therapeutics, Inc. | Healthcare | 1.48% | $1.6M | $1.81B | — |
| 25 | WGS | GeneDx Holdings Corp. | Healthcare | 1.26% | $1.3M | $1.90B | — |
| 26 | AZN | AstraZeneca PLC | Healthcare | 1.25% | $1.3M | — | — |
| 27 | RARE | Ultragenyx Pharmaceutical Inc. | Healthcare | 1.11% | $1.2M | $1.43B | — |
| 28 | DHR | Danaher Corporation | Healthcare | 1.04% | $1.1M | $161.01B | 40.8 |
| 29 | NTLA | Intellia Therapeutics, Inc. | Healthcare | 0.94% | $993,975.98 | $1.60B | — |
| 30 | BMY | Bristol-Myers Squibb Company | Healthcare | 0.90% | $955,457.16 | $122.05B | 13.2 |
| 31 | QURE | uniQure N.V. | Healthcare | 0.90% | $951,541.78 | $1.51B | — |
| 32 | STOK | Stoke Therapeutics, Inc. | Healthcare | 0.88% | $936,409.39 | $1.56B | — |
| 33 | VIR | Vir Biotechnology, Inc. | Healthcare | 0.88% | $935,033.72 | $1.69B | — |
| 34 | PSNL | Personalis, Inc. | Healthcare | 0.77% | $817,043.39 | $1.67B | — |
| 35 | MRVI | Maravai LifeSciences Holdings, Inc. | Healthcare | 0.57% | $603,602.57 | $2.51B | — |
| 36 | WVE | Wave Life Sciences Ltd. | Healthcare | 0.41% | $431,961.03 | $616.8M | — |
| 37 | PACB | Pacific Biosciences of California, Inc. | Healthcare | 0.38% | $397,357.58 | $537.7M | — |
| 38 | MYGN | Myriad Genetics, Inc. | Healthcare | 0.35% | $371,960.56 | $380.7M | — |
| 39 | A | Agilent Technologies, Inc. | Healthcare | 0.34% | $361,272.65 | $48.77B | 34.1 |
| 40 | BRKR | Bruker Corporation | Healthcare | 0.31% | $332,383.53 | $8.35B | — |
| 41 | FLGT | Fulgent Genetics, Inc. | Healthcare | 0.31% | $325,822.64 | $545.1M | — |
| 42 | PRME | Prime Medicine, Inc. | Healthcare | 0.28% | $292,171.58 | $629.4M | — |
| 43 | MLAB | Mesa Laboratories, Inc. | Technology | 0.27% | $288,362.03 | $685.4M | 144.1 |
| 44 | DGX | Quest Diagnostics Incorporated | Healthcare | 0.26% | $273,229.64 | $25.94B | 24.6 |
| 45 | RGNX | REGENXBIO Inc. | Healthcare | 0.26% | $272,806.35 | $457.1M | — |
| 46 | BNTC | Benitec Biopharma Inc. | Healthcare | 0.21% | $222,223.95 | $282.9M | — |
| 47 | EDIT | Editas Medicine, Inc. | Healthcare | 0.19% | $199,789.91 | $360.9M | — |
| 48 | RCKT | Rocket Pharmaceuticals, Inc. | Healthcare | 0.18% | $186,985.58 | $239.3M | — |
| 49 | FLDM | Fluidigm Corporation | Healthcare | 0.14% | $151,958.85 | — | — |
| 50 | CRBU | Caribou Biosciences, Inc. | Healthcare | 0.05% | $51,323.15 | $50.4M | — |
Weights as a percentage of net assets. Value held = weight × net assets ($105.8M). Market cap and P/E from each company's latest fundamentals (U.S.-listed stocks).
GNOM sector breakdown
Sum of the weights of the holdings in each sector.
GNOM top industries
GNOM overlap with other ETFs
| ETF | Fund | Overlap | Shared holdings | Expense ratio |
|---|---|---|---|---|
| SPY | SPDR S&P 500 ETF | 2.7% | 10 of 502 | 0.09% |
| VTI | Vanguard Total Stock Market ETF | 2.6% | 42 of 2,941 | 0.03% |
| IWM | iShares Russell 2000 ETF | 1.8% | 26 of 1,962 | 0.19% |
| QQQ | Invesco QQQ ETF | 1.8% | 3 of 101 | 0.17% |
| VXUS | Vanguard Total International Stock ETF | 0.6% | 5 of 8,035 | 0.05% |
| DIA | SPDR Dow Jones Industrial Average ETF | 0.0% | 0 of 30 | 0.16% |
Overlap = sum over shared holdings of the smaller of the two weights. 100% means identical portfolios.
About the GNOM portfolio
Global X Genomics & Biotechnology ETF holds 50 positions. The ten largest make up 54.1% of the fund, so it behaves like a portfolio of about 22 equally weighted stocks. The biggest positions are Moderna, Inc. (12.18%), Twist Bioscience Corporation (6.06%), 10x Genomics, Inc. (5.99%), Illumina, Inc. (5.85%), Natera, Inc. (5.26%).
By sector, Healthcare is 98.2%, Technology is 0.3%. Holdings data is from the fund's latest portfolio as reported by EODHD on October 24, 2026; positions change as the fund rebalances.
Related: GNOM chart, GNOM performance, GNOM dividends, GNOM overview.
GNOM holdings FAQ
How many holdings does GNOM have?
GNOM holds 50 positions as of October 24, 2026.
What are the top 10 holdings of GNOM?
The ten largest holdings are Moderna, Inc. (12.18%), Twist Bioscience Corporation (6.06%), 10x Genomics, Inc. (5.99%), Illumina, Inc. (5.85%), Natera, Inc. (5.26%), Guardant Health, Inc. (5.01%), Bio-Techne Corporation (3.45%), Genscript Biotech Corp (3.45%), Qiagen N.V. (3.41%), Vertex Pharmaceuticals Incorporated (3.41%). Together they are 54.1% of the fund.
What percentage of GNOM is Moderna, Inc.?
Moderna, Inc. is the largest holding at 12.18% of net assets, about $12.9M of the fund's $105.8M.
How concentrated is GNOM?
The top 10 holdings are 54.1% of the fund. By the effective number of holdings (1 divided by the sum of squared weights) GNOM behaves like a portfolio of about 22 equally weighted stocks.